Today: 7 February 2026
Subscribe

Chevron stock edges higher after-hours as Venezuela crude shift puts CVX in focus

Chevron stock edges higher after-hours as Venezuela crude shift puts CVX in focus

Chevron shares rose 0.9% to $163.87 after hours Tuesday as sources said the company plans to process Venezuelan crude at U.S. refineries in Texas and Mississippi. U.S. crude futures traded at a $4.76 discount to Brent, the widest since April, amid expectations of Venezuelan shipments resuming. Oil prices jumped over 2% on Iran supply fears. Exxon CEO called Venezuela “uninvestable” without legal reforms.
14 January 2026
···
Applied Materials (AMAT) stock slips after hours despite Susquehanna upgrade and new $325 target

Applied Materials (AMAT) stock slips after hours despite Susquehanna upgrade and new $325 target

Applied Materials shares fell 0.8% to $304.87 Tuesday, holding steady after hours despite upgrades from Susquehanna and Bernstein. Susquehanna raised its target to $400, citing strong chip equipment spending, while Bernstein lifted its target to $325 but kept a neutral rating. Broader chip equipment stocks were mixed as the S&P 500 slipped 0.2%. Applied reports earnings Feb. 12.
14 January 2026
·
Citigroup stock slips after hours as job cuts, credit-card cap talk collide ahead of earnings

Citigroup stock slips after hours as job cuts, credit-card cap talk collide ahead of earnings

Citigroup shares fell 1.2% to $116.30 in after-hours trading Tuesday after a source said the bank will cut about 1,000 jobs this week, part of a plan to reduce its workforce by 20,000 by 2026. The move comes as Citi faces a Supreme Court setback, a proposed federal credit card rate cap, and heightened investor scrutiny ahead of its fourth-quarter earnings report Wednesday.
14 January 2026
··
Wells Fargo stock slides after-hours ahead of earnings as credit-card cap jitters hit banks

Wells Fargo stock slides after-hours ahead of earnings as credit-card cap jitters hit banks

Wells Fargo shares fell 1.5% to $93.56 in after-hours trading Tuesday ahead of its fourth-quarter earnings release. The drop followed a broader decline in U.S. financial stocks, pressured by a proposed 10% cap on credit-card interest rates. Analysts expect Wells Fargo to report $1.66 per share on $21.6 billion in revenue. The bank’s results arrive as investors watch for signs of margin pressure and shifts in rate policy.
14 January 2026
··
IREN Limited stock pops after-hours as H.C. Wainwright flips to Buy, lifts target to $80

IREN Limited stock pops after-hours as H.C. Wainwright flips to Buy, lifts target to $80

IREN Limited shares rose 5.3% to $52.99 in after-hours trading after H.C. Wainwright upgraded the stock to Buy and raised its price target to $80. The move follows IREN’s $9.7 billion AI Cloud deal with Microsoft and a $2.3 billion convertible notes offering. Bitcoin’s 4.4% climb to $95,155 also lifted crypto miners. IREN’s next earnings report is scheduled for Feb. 11.
14 January 2026
·
Capital One stock slips after hours as Trump’s credit-card cap threat hangs over COF

Capital One stock slips after hours as Trump’s credit-card cap threat hangs over COF

Capital One shares fell 0.7% to $231.41 in after-hours trading Tuesday, following a steep drop Monday as investors reacted to Trump’s proposal to cap credit-card rates at 10%. A federal judge granted preliminary approval to Capital One’s $425 million settlement for depositors claiming underpaid interest. JPMorgan executives warned the rate cap could tighten credit. A final court hearing on the settlement is set for April 20.
14 January 2026
·
Coinbase stock jumps after-hours as Senate crypto bill targets stablecoin rewards

Coinbase stock jumps after-hours as Senate crypto bill targets stablecoin rewards

Coinbase shares rose about 4% in after-hours trading Tuesday after U.S. senators introduced a draft bill to expand CFTC oversight of spot-crypto markets and restrict stablecoin interest payouts. The Senate Banking Committee will review the bill Thursday. Bitcoin climbed 4.6% to $95,300. Traders are watching the bill’s progress and the upcoming Fed meeting for signals on rates.
14 January 2026
···
Eli Lilly stock in focus after hours as FDA moves on Zepbound label and pill race tightens

Eli Lilly stock in focus after hours as FDA moves on Zepbound label and pill race tightens

Eli Lilly shares fell 0.4% after hours to $1,077.19 as the FDA told drugmakers to remove suicide warnings from GLP-1 weight-loss drugs, including Lilly’s Zepbound. At the JPMorgan Healthcare Conference, Lilly and rivals pitched new obesity pills and longer-acting shots, with Lilly targeting a second-quarter U.S. approval for its oral drug. Amgen and Novo Nordisk highlighted new data and launches in the crowded obesity market.
14 January 2026
··
Johnson & Johnson stock pops on court win — what traders watch before earnings

Johnson & Johnson stock pops on court win — what traders watch before earnings

Johnson & Johnson shares rose 1.9% to $213.65 Tuesday and held steady after hours as Delaware’s top court ordered a recalculation of a $1 billion damages award tied to the Auris Health acquisition. The ruling could reduce the payout by several hundred million dollars. Investors are watching for J&J’s fourth-quarter results on Jan. 21 and updates from healthcare conferences this week.
14 January 2026
··
Bank of America stock drops as Trump’s credit-card cap plan raises the stakes before earnings

Bank of America stock drops as Trump’s credit-card cap plan raises the stakes before earnings

Bank of America shares fell 1.2% to $54.54 in after-hours trading Tuesday as investors weighed a proposed 10% cap on credit-card interest rates. The move follows declines across big banks after Donald Trump called for the cap to start Jan. 20. Investors are focused on Bank of America’s net interest income and guidance ahead of quarterly results. U.S. December CPI rose 0.3%, adding pressure to the sector.
14 January 2026
··
Robinhood stock rises after CPI print; traders eye Fed decision and Feb earnings

Robinhood stock rises after CPI print; traders eye Fed decision and Feb earnings

Robinhood shares closed up 2.3% at $120.24 Tuesday, steady after hours, as December CPI held at 2.7% year-on-year. The inflation data kept attention on the upcoming Federal Reserve meeting Jan. 27-28 and Robinhood’s earnings set for Feb. 10. Richmond Fed President Tom Barkin called the inflation figures “encouraging.” Crypto and retail-trading stocks mostly tracked rate expectations.
14 January 2026
···
Salesforce stock tumbles 7% as AI payoff worries hit software; Slackbot rollout in focus

Salesforce stock tumbles 7% as AI payoff worries hit software; Slackbot rollout in focus

Salesforce shares fell about 7% Tuesday, closing at $241.06 and extending losses after hours amid concerns over AI disruption and pricing models. Oppenheimer’s downgrade of Adobe intensified selling across application software. Salesforce’s drop was its steepest since May 2024, according to Dow Jones data. The company began rolling out a new AI-powered Slackbot to Business+ and Enterprise+ customers.
14 January 2026
··
1 … 409 410 411 412 413 … 1,631

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop